Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Breast (All Stages^), 2016-2020

Black Non-Hispanic, Female, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Maine6


Idaho7


Utah7


New Hampshire6


Arizona6


Alaska6


Washington5


New Mexico7


Minnesota6


Florida6


West Virginia6


Michigan6


Oregon6


Tennessee6


Colorado6


Hawaii7


Massachusetts7


Rhode Island6


Arkansas6


California7


Texas7


Nebraska6


Pennsylvania6


Ohio6


New York7


South Carolina6


Mississippi6


Oklahoma6


Alabama6


Connecticut7


Virginia6


Iowa7


Georgia7


Kentucky7


Maryland6


Missouri6


Illinois7


New Jersey7


Louisiana7


Kansas6


Delaware6


District of Columbia6


North Carolina6


Wisconsin6


Indiana6 Montana6 Nevada6 North Dakota6 Puerto Rico6 South Dakota6 Vermont6 Wyoming6

Notes:
Created by statecancerprofiles.cancer.gov on 07/08/2024 12:13 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Montana, Nevada, North Dakota, Puerto Rico, South Dakota, Vermont, Wyoming

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
¶¶¶ Data for Puerto Rico is only available for All Races (includes Hispanics). For more information see data not available.
§§, §§§ Data not available for this combination of geography, statistic, age, and race/ethnicity.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.